These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1837523

  • 1. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.
    Kidd EJ, Garratt JC, Marsden CA.
    Eur J Pharmacol; 1991 Jul 23; 200(1):131-9. PubMed ID: 1837523
    [Abstract] [Full Text] [Related]

  • 2. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S, Kreider MS, McGonigle P, Lucki I.
    Brain Res; 1990 Jun 18; 520(1-2):291-302. PubMed ID: 1698505
    [Abstract] [Full Text] [Related]

  • 3. Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex.
    Wright IK, Garratt JC, Marsden CA.
    Br J Pharmacol; 1990 Feb 18; 99(2):221-2. PubMed ID: 1691671
    [Abstract] [Full Text] [Related]

  • 4. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 18; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI.
    Garratt JC, Kidd EJ, Wright IK, Marsden CA.
    Eur J Pharmacol; 1991 Jul 09; 199(3):349-55. PubMed ID: 1915582
    [Abstract] [Full Text] [Related]

  • 7. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1991 Jun 04; 105(2):219-24. PubMed ID: 1839064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 04; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.